最近在通过PROTACs和替代向蛋白质降解技术降解膜蛋白的进展
Siyu Chen1, Jingliang Cui1, Haiyan Chen1
1Key Laboratory for Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, Hubei Engineering Research Center for Advanced Fine Chemicals, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, 206 1st Rd Optics Valley, East Lake New Technology Development District, Wuhan, Hubei, 430205, China.
European journal of medicinal chemistry
|November 4, 2023
概括
向蛋白降解 (TPD) 提供了一种新的癌症治疗方法,克服药物耐药性. 像PROTACs和LYTACs这样的新方法专门降解引起疾病的膜蛋白,推进癌症治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 向蛋白降解 (TPD) 是癌症治疗的一个关键策略,旨在消除癌症的根源原因并规避耐药性.
- 蛋白质解离向嵌合体 (PROTACs) 利用无素-蛋白质酶系统 (UPS) 来降解瘤细胞内的向蛋白质.
- 虽然PROTACs主要向细胞内蛋白质,但也实现了膜蛋白降解 (例如EGFR,ALK,PD-L1,GPCR).
研究的目的:
- 审查和讨论新兴的膜蛋白降解技术.
- 分析这些新策略的优点,缺点和潜在应用.
- 为开发未来一般膜蛋白降解方法提供见解.
主要方法:
- 对针对性蛋白质降解技术的科学文献的审查.
- 对 PROTAC 和相关新兴策略 (AbTAC,LYTAC,分子,Nano-PROTAC) 的分析.
- 讨论每个技术的机制,好处和局限性.
主要成果:
- PROTAC和其他TPD策略可以有效地降解与癌症有关的各种膜蛋白.
- 新兴的技术,如基于抗体的PROTACs (AbTACs),化体向的仿真体 (LYTACs),分子和基于纳米粒子的PROTACs (纳米PROTACs) 提供了替代的降解途径.
- 每种方法都在目标特异性,效率和交付方面都有独特的优点和缺点.
结论:
- 膜蛋白降解是瘤学中一个有前途的治疗途径.
- 目前正在开发各种TPD策略,以针对具有挑战性的膜蛋白.
- 对这些技术的进一步研究可能会导致更有效和更普遍的癌症疗法.
相关概念视频
Regulated Protein Degradation
2.5K
2.5K
The Proteasome
8.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.7K
The Proteasome Structure
773
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
773
Detergent Purification of Membrane Proteins
5.2K
Detergents are used to purify the integral proteins of the membrane. The hydrophobic portion of the detergent can replace membrane phospholipids while solubilizing the membrane proteins. When detergent monomers reach a specific concentration in a solution called critical micelle concentration (CMC), they form micelles. Above CMC, the concentration of the detergent monomers remains in equilibrium with the micelle. The number of detergent monomers present in the CMC varies for each detergent, and...
5.2K
Tagging and Fusion Proteins
6.7K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.7K
Mitochondrial Precursor Proteins
2.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.6K


